Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation

ClinicalTrials.gov ID: NCT02163824

Public ClinicalTrials.gov record NCT02163824. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Double-Masked, Randomized, Controlled Trial of KPI-121 in Postsurgical Inflammation

Study identification

NCT ID
NCT02163824
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kala Pharmaceuticals, Inc.
Industry
Enrollment
380 participants

Conditions and interventions

Interventions

  • KPI-121 0.25% Drug
  • KPI-121 1.0% Drug
  • Vehicle of KPI-121 0.25% Drug
  • Vehicle of KPI-121 1.0% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2014
Primary completion
Nov 30, 2014
Completion
Nov 30, 2014
Last update posted
Jan 28, 2021

2014

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
Sall Research Medical Center Artesia California 90701
North Valley Eye Medical Group Mission Hills California 91345
Martel Eye Medical Group Rancho Cordova California 95670
Wolstan & Goldberg Eye Associates Torrance California 90505
Clayton Eye Center Morrow Georgia 30260
Price Vision Group Indianapolis Indiana 46260
John-Kenyon American Eye Institute New Albany Indiana 47150
Taustine Eye Center Louisville Kentucky 40217
Tauber Eye Center Kansas City Missouri 64111
Tekwani Vision Center St Louis Missouri 63128
Ophthalmology Associates St Louis Missouri 63131
Ophthalmology Consultants St Louis Missouri 63131
Las Vegas Physicians Research Group Henderson Nevada 89052
Raymond Fong, MDPC New York New York 10013
Rochester Ophthalmological Group, PC Rochester New York 14618
Cornerstone Eye Care High Point North Carolina 27262
Cincinnati Eye Institute Cincinnati Ohio 45242
The Eye Center of Columbus Columbus Ohio 43215
Westside Research, LLC Spartanburg South Carolina 29306
The Eye Clinic of Texas, Affiliate of Houston Eye Associates League City Texas 77573
R&R Eye Research, LLC San Antonio Texas 78229
Kozlovsky Delay & Winter Eye Consultants, LLC San Antonio Texas 78230
Virginia Eye Consultants Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02163824, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02163824 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →